1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Schibli, D.J. Hwang, P.M. Vogel, H.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 38 16749 16755 10.1021/bi990701c 10606506 Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. 1999 NE FEBS Lett. FEBLAL 0165 0014-5793 390 95 98 10.1016/0014-5793(96)00637-0 Antimicrobial Activity of a 13 Amino Acid Tryptophan-Rich Peptide Derived From a Putative Porcine Precursor Protein of a Novel Family of Antibacterial Peptides 1996 10.2210/pdb1d6x/pdb pdb_00001d6x 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1906.286 ANTIMICROBIAL PEPTIDE, TRITRPTICIN SYNTHETIC CATHELICIDIN FRAGMENT 1 syn polymer no no VRRFPWWWPFLRR VRRFPWWWPFLRR A polypeptide(L) n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2000-01-03 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name RCSB Y RCSB 1999-10-15 REL REL SYNTHETIC PEPTIDE, SEQUENCE FROM A FRAGMENT OF A PORCINE NEUTROPHIL CATHELICIDIN sample THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES structures with favorable non-bond energy 97 19 2D NOESY DQF-COSY TOCSY 2D NOESY TOCSY 400 mM SDS 4.5 AMBIENT 313 K THE STRUCTURES ARE BASED ON 163 INTERPROTON RESTRAINTS. OF THESE 47 WERE INTRARESIDUE, 50 SEQUENTIAL, AND 66 SHORT-RANGE RESTRAINED SIMULATED ANNEALING MOLECULAR DYNAMICS 19 minimized average structure 3 MM TRITRPTICIN, 400 MM PERDEUTERATED SDS 3 MM TRITRPTICIN, 400 MM PERDEUTERATED SDS DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER, BAX processing NMRPipe 5.0 BRUNGER, ADAMS, CLORE, DELANO, GROS, GROSSE-KUNSTLEVE, JIANG, KUSZEWSKI, NILGES, PANNU, READ, RICE, SIMONSON, WARREN refinement CNS 0.9 500 Bruker AMX VAL 1 n 1 VAL 1 A ARG 2 n 2 ARG 2 A ARG 3 n 3 ARG 3 A PHE 4 n 4 PHE 4 A PRO 5 n 5 PRO 5 A TRP 6 n 6 TRP 6 A TRP 7 n 7 TRP 7 A TRP 8 n 8 TRP 8 A PRO 9 n 9 PRO 9 A PHE 10 n 10 PHE 10 A LEU 11 n 11 LEU 11 A ARG 12 n 12 ARG 12 A ARG 13 n 13 ARG 13 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A O H PRO TRP 5 8 1.44 2 A A O H TRP LEU 8 11 1.55 5 A A O H TRP LEU 8 11 1.56 6 A A O H TRP LEU 8 11 1.59 10 A A O H TRP LEU 8 11 1.54 15 A A O H TRP LEU 8 11 1.54 18 A A O H TRP LEU 8 11 1.54 1 A ARG 3 -175.07 -38.18 1 A PHE 4 -34.73 96.81 1 A PRO 5 -66.58 -148.31 1 A PRO 9 -34.83 -33.50 1 A ARG 12 -175.16 -69.61 2 A PHE 4 -34.50 92.66 2 A TRP 6 -34.85 -29.24 2 A PRO 9 -39.91 -38.49 2 A LEU 11 -52.52 -179.32 3 A PHE 4 -35.53 96.89 3 A PRO 5 -67.51 -149.44 3 A PRO 9 -35.00 -31.93 4 A PHE 4 -34.83 95.87 4 A PRO 5 -68.69 -147.83 4 A PRO 9 -36.59 -31.73 5 A ARG 3 -175.15 -46.09 5 A PRO 5 -70.54 -143.18 5 A PRO 9 -34.13 -33.37 5 A ARG 12 -140.97 -67.49 6 A PHE 4 -34.93 95.14 6 A PRO 5 -69.80 -147.33 6 A LEU 11 -52.75 -178.68 7 A ARG 3 -96.35 39.07 7 A PHE 4 -35.03 95.62 7 A PRO 5 -67.88 -150.83 7 A PRO 9 -34.85 -32.28 7 A ARG 12 -161.16 35.06 8 A PHE 4 -34.90 95.90 8 A PRO 5 -68.72 -149.19 8 A PRO 9 -33.86 -32.64 8 A ARG 12 -129.54 -61.54 9 A PHE 4 -35.71 96.33 9 A PRO 5 -68.92 -147.71 9 A PRO 9 -34.05 -31.07 10 A ARG 3 -108.41 59.65 10 A PHE 4 -34.76 95.14 10 A PRO 5 -69.58 -147.77 10 A LEU 11 -48.45 -78.64 10 A ARG 12 -59.22 -76.66 11 A ARG 3 -96.98 42.46 11 A PHE 4 -34.94 95.82 11 A PRO 5 -67.50 -150.06 11 A PRO 9 -34.79 -32.22 12 A PHE 4 -34.73 95.22 12 A PRO 5 -69.06 -149.83 12 A PRO 9 -34.73 -32.47 12 A ARG 12 -175.05 124.16 13 A ARG 2 -60.00 -176.30 13 A ARG 3 -153.20 30.51 13 A PHE 4 -34.93 95.73 13 A PRO 5 -69.15 -148.20 13 A PRO 9 -34.80 -33.13 13 A ARG 12 -175.14 145.29 14 A PHE 4 -34.81 95.65 14 A PRO 5 -68.05 -149.50 14 A PRO 9 -35.00 -33.88 14 A ARG 12 -152.90 -47.00 15 A ARG 3 -68.98 70.41 15 A PHE 4 -34.87 95.62 15 A PRO 5 -69.62 -146.22 15 A PRO 9 -34.41 -32.38 16 A ARG 2 -59.06 170.19 16 A PHE 4 -34.88 96.19 16 A PRO 5 -69.70 -147.51 16 A PRO 9 -34.54 -33.61 17 A ARG 3 -175.06 -37.02 17 A PHE 4 -34.91 96.61 17 A PRO 5 -66.76 -149.91 17 A PRO 9 -35.84 -31.59 17 A LEU 11 -87.94 38.31 18 A PHE 4 -35.44 96.15 18 A PRO 5 -69.31 -147.28 18 A PRO 9 -34.54 -32.21 19 A ARG 2 -59.69 -168.82 19 A ARG 3 -154.52 29.84 19 A PHE 4 -38.65 98.70 19 A PRO 5 -63.64 -87.34 19 A TRP 6 -175.33 -35.55 19 A PRO 9 -35.05 -33.63 minimized average THE STRUCTURE OF THE ANTIMICROBIAL PEPTIDE TRITRPTICIN BOUND TO MICELLES-A DISTINCT MEMBRANE-BOUND PEPTIDE FOLD 1 N N A TRP 7 A TRP 7 HELX_P A LEU 11 A LEU 11 5 1 5 IMMUNE SYSTEM TYPE IV TURN-TYPE III TURN, IMMUNE SYSTEM 1D6X PDB 1 1D6X 1 13 1D6X 1 13 1D6X A 1 1 13 1 P 1